Dennis McLoughlin - 04 Jun 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Customer Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
04 Jun 2021
Net transactions value
-$115,665
Form type
4
Filing time
08 Jun 2021, 16:15:38 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $115,665 -1,895 -6.4% $61.04 27,541 04 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes 355 and 183 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020 and December 2020, respectively.